Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0RM6A
|
|||
| Former ID |
DIB016980
|
|||
| Drug Name |
RST-001
|
|||
| Synonyms |
ChR2 gene therapy (retinopathy), RetroSense; AAV-based ChR2 gene therapy (retinopathy), RetroSense; Channelrhodopsin-2 gene therapy (retinopathy), RetroSense
Click to Show/Hide
|
|||
| Indication | Retinopathy [ICD-11: 9B71] | Phase 1/2 | [1] | |
| Company |
RetroSense Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02556736) RST-001 Phase I/II Trial for Retinitis Pigmentosa. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.